MRI Used to Detect Local Prostate Cancer Recurrence After Prostatectomy

Oncology NEWS InternationalOncology NEWS International Vol 6 No 3
Volume 6
Issue 3

CHICAGO--Because of its high cost and lack of universal availability, magnetic resonance imaging (MRI) has not been a prominent tool in the initial evaluation of prostate cancer. However, MRI is proving to be a highly accurate method of identifying local recurrence of prostate cancer after radical prostatec-tomy, Jeffrey M. Silverman, MD, said at the Radiological Society of North America (RSNA) annual meeting.

CHICAGO--Because of its high cost and lack of universal availability,magnetic resonance imaging (MRI) has not been a prominent tool in the initialevaluation of prostate cancer. However, MRI is proving to be a highly accuratemethod of identifying local recurrence of prostate cancer after radicalprostatec-tomy, Jeffrey M. Silverman, MD, said at the Radiological Societyof North America (RSNA) annual meeting.

Using endorectal surface coil MR imaging, Dr. Silverman and his colleaguesat Cedars-Sinai Medical Center, Los Angeles, prospectively analyzed 41men who had undergone radical prostatectomy an average of 26 months previously.

Thirty-five men had clinical suspicion of recurrent prostate cancerbecause of an elevated PSA level or the presence of a nodule or indurationon digital rectal examination. Six men served as controls because theyhad no signs of recurrence.

The men had four MRI sequences--a sagittal series of fat-saturated T2-weightedfast spin echo images, fat-saturated axial T2-weighted fast spin echo images,fat-saturated axial T1-weighted images, and fat-saturated axial T1-weightedimages after gadolinium enhancement.

All 31 men who were suspected of having recurrent cancer because ofhigher than usual PSA levels exhibited a prostate bed soft tissue noduleon MRI. The nodules were isointense compared to skeletal muscle on T1-weightedimages, hyperintense on T2-weighted images, and all were obviously enhancedafter gadolinium administration, he said.

Four men with a palpable nodule or induration detected at digital rectalexamination but stable PSA levels had fibrosis, and, in every case, MRimaging revealed no abnormality. The six men who had no clinical evidenceof recurrent prostate cancer also had unremarkable MR scans.

The sensitivity and specificity of endorectal surface coil MRI detectionof local recurrence was 100% in the study. Dr. Silverman concluded, therefore,that "endorectal surface coil MR imaging is a useful tool for menwho have undergone radical prostatectomy and are suspected of having localrecurrence of disease."

Related Videos
An expert from Weill Cornell Medicine highlights key clinical data indicating the benefits of radium-223 in the treatment of patients with metastatic castration-resistant prostate cancer.
The risk of radionuclide exposure to the public reflects one reason urologists need to collaborate with radiation oncologists when administering radiopharmaceuticals to patients with prostate cancer.
Switching out beta emitters for alpha emitters, including radium-223, is one way to improve radiopharmaceutical treatment of prostate cancer, according to an expert from Weill Cornell Medicine.
Expert cardiologist
Expert urologist
Expert cardiologist
Expert urologist
Expert urologist
Expert urologist
Expert oncologist
Related Content